Commercialisation Agreement For SeptiCyte RAPID Test

Biocartis NV

26/03/2020 06:09

March 26 (Reuters) - BIOCARTIS GROUP NV  BCART.BR :
    * BIOCARTIS ANNOUNCES CO-COMMERCIALIZATION OF THE SEPTICYTE®
RAPID
TEST ON IDYLLA™ (CE-IVD) AND PROVIDES UPDATE ON COVID-19 IMPACT
    * COVID-19: EXPECTS THAT CURRENT PROLONGED MEASURES TAKEN IN
MANY
COUNTRIES ACROSS GLOBE MAY POTENTIALLY IMPACT FY 2020 OUTLOOK OF
COMPANY

Source text for Eikon:  ID:nGNE72F2HT 
Further company coverage:  BCART.BR 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48587785110;))